# Project Tasks from Whitepaper

This document lists key tasks derived from the Biocybernetic Nanoneural Skin whitepaper.
It can be used as a reference for creating GitHub Issues and tracking progress.

## Phase I: Material Optimization & Bench Tests (2025–2026)

### System Architecture - Core Layers
- [ ] `[Task]` Research & Optimize: Inner Hydrogel Layer (Peptide-based, micro-reservoirs) <!-- Labels: research, materials, phase-I -->
- [ ] `[Task]` Develop & Test: Silicone Adhesive Mesh (Medical-grade, atraumatic) <!-- Labels: development, materials, phase-I -->
- [ ] `[Task]` Design & Fabricate: Elastomeric Shell (PDMS/PU, CNT pigmented, 3D-printed/cast) <!-- Labels: design, hardware, phase-I -->

### Roadmap & Milestones - Phase I
- [ ] `[Task]` Conduct: Bench tests for mechanical, fluidic, biological compatibility of materials <!-- Labels: testing, materials, phase-I -->
- [ ] `[Documentation]` Achieve TRL 3 for core materials and basic system concept <!-- Labels: documentation, phase-I -->

### Risk Mitigation - Phase I
- [ ] `[Task]` Conduct: ISO 10993 cytotoxicity tests for biocompatibility <!-- Labels: testing, regulatory, phase-I -->

## Phase II: E-Skin Integration & Animal Studies (2026–2028)

### System Architecture - Core Layers
- [ ] `[Task]` Integrate & Validate: Flexible e-Skin Sensors (AgNW/MXene, BLE) <!-- Labels: integration, hardware, phase-II -->

### System Architecture - Near-Term Integration
- [ ] `[Task]` Develop & Implement: Edge AI Controller (ARM Cortex-M, anomaly detection ML model) <!-- Labels: development, firmware, ml, phase-II -->
- [ ] `[Task]` Design & Test: Power Harvesting System (Piezoelectric, Thermoelectric, Li-ion backup) <!-- Labels: design, hardware, phase-II -->
- [ ] `[Task]` Develop & Secure: Cloud Interface (HIPAA, E2EE, EHR integration) <!-- Labels: development, software, phase-II -->

### Roadmap & Milestones - Phase II
- [ ] `[Task]` Conduct: Animal studies (rodents) for integrated system (e-skin, Edge AI, power) <!-- Labels: testing, clinical, phase-II -->
- [ ] `[Documentation]` Achieve TRL 4-5 for integrated near-term system <!-- Labels: documentation, phase-II -->

### Risk Mitigation - Phase II
- [ ] `[Task]` Perform: In vivo fibrosis assays in porcine models (12 wk) for immune response <!-- Labels: testing, clinical, phase-II -->
- [ ] `[Security]` Implement & Audit: Data security measures (BLE pairing, AES-256, HIPAA/GDPR) <!-- Labels: security, software, phase-II -->
- [ ] `[Task]` Design & Test: Redundant power harvesters and low-power ML strategies <!-- Labels: hardware, firmware, phase-II -->

## Phase III: Human Trials & Regulatory Filing (2028–2030)

### Clinical Use Case
- [ ] `[Clinical]` Plan & Execute: Pilot Studies for Neonatal EB & Ichthyosis (n=20 per center) <!-- Labels: clinical, phase-III -->
- [ ] `[Clinical]` Define & Track: Endpoint Metrics (Time-to-heal, pain scores, etc.) <!-- Labels: clinical, phase-III -->

### Roadmap & Milestones - Phase III
- [ ] `[Regulatory]` Prepare & File: CE/FDA IDE for human trials <!-- Labels: regulatory, phase-III -->
- [ ] `[Clinical]` Conduct: Human safety and efficacy trials (neonatal EB patients) <!-- Labels: clinical, phase-III -->
- [ ] `[Documentation]` Achieve TRL 6 for pre-market medical device <!-- Labels: documentation, phase-III -->

### Risk Mitigation - Phase III
- [ ] `[Regulatory]` Engage: FDA for Breakthrough Device designation <!-- Labels: regulatory, phase-III -->
- [ ] `[Regulatory]` Prepare: CE marking under MDR documentation <!-- Labels: regulatory, phase-III -->

### Market & Commercial Strategy - Phase III
- [ ] `[BizDev]` Develop: Go-to-Market strategy for Medical Edition (Direct-to-clinic, medtech suppliers) <!-- Labels: business, phase-III -->

## Phase IV: Regulatory Approvals & Launch (2030–2032)

### Roadmap & Milestones - Phase IV
- [ ] `[Regulatory]` Obtain: Regulatory approvals (Class II/III) for Medical Edition <!-- Labels: regulatory, phase-IV -->
- [ ] `[Ops]` Establish & Scale: Manufacturing processes for Medical Edition <!-- Labels: manufacturing, phase-IV -->
- [ ] `[Product]` Launch: Medical Edition of Biocybernetic Skin <!-- Labels: product, phase-IV -->

### Market & Commercial Strategy - Phase IV
- [ ] `[BizDev]` Plan: DTC online platform with subscription model for hydrogel refills <!-- Labels: business, software, phase-IV -->

## Phase V: Consumer Launch & Nanorobotic R&D Translation (2032–2035)

### System Architecture - Future Nanorobotic Layer
- [ ] `[R&D]` Investigate: DNA-Origami Logic Gates for molecular sensing <!-- Labels: research, nanobots, phase-V -->
- [ ] `[R&D]` Explore: Molecular Motors & Self-Assembly for on-skin adaptation <!-- Labels: research, nanobots, phase-V -->
- [ ] `[R&D]` Prototype: Memristive Neuromorphic Fabric (Flexible RRAM) <!-- Labels: research, nanobots, hardware, phase-V -->

### Roadmap & Milestones - Phase V
- [ ] `[Product]` Launch: Consumer Light & Premium Editions <!-- Labels: product, phase-V -->
- [ ] `[R&D]` Translate: Nanorobotic R&D findings into product development path <!-- Labels: research, nanobots, phase-V -->

## Ongoing / General Tasks

### Open Collaboration & Licensing
- [ ] `[Documentation]` Maintain: GitHub repository with source, CAD, ML scripts, protocols (MIT License) <!-- Labels: documentation, community -->
- [ ] `[Documentation]` Create: LICENSE file (MIT) <!-- Labels: documentation, legal -->
- [ ] `[Community]` Publish: Preprints on arXiv/bioRxiv for research and clinical studies <!-- Labels: community, research, clinical -->
- [ ] `[Community]` Prepare & Release: Datasets on Zenodo with DOI <!-- Labels: community, data -->
- [ ] `[Community]` Plan: Participation and presentations at relevant conferences <!-- Labels: community, research -->
